SCHEMBL2018383

SCHEMBL2018383

Clc1cc2ncccc2c2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
MAPT P10636 6/20 0.54
KDM4E B2RXH2 5/20 0.54
NR4A2 P43354 2/20 0.52
L3MBTL1 Q9Y468 3/20 0.48
CCR1 P32246 2/20 0.48
CCR8 P51685 2/20 0.48
CYP3A4 P08684 3/20 0.48
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
MMP14 P50281 3/20 0.47
LMNA P02545 3/20 0.47
HSP90AA1 P07900 3/20 0.47
ALOX15 P16050 3/20 0.47
TDP1 Q9NUW8 3/20 0.47
TP53 P04637 2/20 0.47
ALOX12 P18054 2/20 0.47
SLC6A2 P23975 2/20 0.47
OPRK1 P41145 2/20 0.47
HTT P42858 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1149641 0.82 L3MBTL1 (0.61) ALDH1A1MAPTKDM4ENR4A2L3MBTL1
SCHEMBL31170791 0.79 NR4A2 (0.52) ALDH1A1MAPTKDM4ENR4A2L3MBTL1
SCHEMBL29702168 0.79 NR4A2 (0.67) ALDH1A1MAPTKDM4ENR4A2L3MBTL1
SCHEMBL7712335 0.79 NR4A2 (0.67) ALDH1A1MAPTKDM4ENR4A2L3MBTL1
SCHEMBL4433754 0.76 NR4A2 (0.58) ALDH1A1MAPTKDM4ENR4A2L3MBTL1
SCHEMBL18572649 0.76 KDM4E (0.53) ALDH1A1MAPTKDM4ENR4A2L3MBTL1
SCHEMBL17839007 0.76 NR4A2 (0.49) ALDH1A1MAPTKDM4ENR4A2L3MBTL1
SCHEMBL7949840 0.76 MAPT (0.49) ALDH1A1MAPTKDM4ENR4A2L3MBTL1
SCHEMBL3454205 0.76 NR4A2 (0.49) ALDH1A1MAPTKDM4ENR4A2L3MBTL1
SCHEMBL17838999 0.76 NR4A2 (0.49) ALDH1A1MAPTKDM4ENR4A2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2327679-B1 NOVEL ANTHRACENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING SAME LG CHEMICAL LTD (KR) 2017-03-01 EP disclosed
EP-2327679-B1 NOVEL ANTHRACENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING SAME LG CHEMICAL LTD (KR) 2017-03-01 EP disclosed
US-8318325-B2 Anthracene derivatives and organic electronic device using same LG CHEM, LTD. (KR) 2012-11-27 US disclosed
US-8318325-B2 Anthracene derivatives and organic electronic device using same LG CHEM, LTD. (KR) 2012-11-27 US disclosed
US-8318325-B2 Anthracene derivatives and organic electronic device using same LG CHEM, LTD. (KR) 2012-11-27 US disclosed
US-20110156017-A1 NOVEL ANTHRACENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING SAME LG CHEM, LTD. (KR) 2011-06-30 US disclosed
US-20110156017-A1 NOVEL ANTHRACENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING SAME LG CHEM, LTD. (KR) 2011-06-30 US disclosed
US-20110156017-A1 NOVEL ANTHRACENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING SAME LG CHEM, LTD. (KR) 2011-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110156017-A1 NOVEL ANTHRACENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING SAME VDAC2, VDAC3, ANXA1 ALDH1A1 626/4885MAPT 3166/4885KDM4E 542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.